MANHASSET, N.Y., May 13, 2019 /PRNewswire/ -- The American Association of Immunologists (AAI) has named Betty Diamond, MD, professor at The Feinstein Institute for Medical Research, to its inaugural class of distinguished fellows. The AAI, an organization founded in 1913 dedicated to advancing the field of immunology and fostering development opportunities for researchers, recognizes active members who have served for 25 or more years for their renowned careers and outstanding scientific contributions, including their service to the organization and immunology community.
Dr. Diamond, an autoimmune disease expert and lupus researcher, has served as an AAI member since 1980, and was president of the association from 2009-2010. She was officially recognized along with other seasoned investigators across the country during AAI's annual meeting, which took place from May 9-13 in San Diego, CA. Election as a Distinguished Fellow will now occur annually and is among the highest honors bestowed by AAI.
"We congratulate Dr. Diamond for the high honors being conferred by AAI," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. "Dr. Diamond's leadership in defining new mechanisms of autoimmune disease give hope of new treatments for patients today and far into the future."
At the Feinstein Institute, Dr. Diamond's laboratory studies DNA-reactive B cells in the autoimmune disease systemic lupus erythematosus. Dr. Diamond and her researchers design studies to provide new strategies to protect against this illness as well as other autoimmune diseases.
For over a century, AAI has fulfilled its founders' mission "to promote by its concerted efforts scientific research." Today, as the most prestigious association of immunologists in the world, AAI continues to champion the interests of its membership, which has grown to nearly 8,000 scientists in 71 countries.
About the Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest health care provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit feinstein.northwell.edu
Contact: David Robbins
SOURCE The Feinstein Institute for Medical Research